Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Direct Meds vs MEDVi

In our scoring, MEDVi edges ahead overall (7.1 vs 6.4 out of 10), and Direct Meds costs less for compounded semaglutide (about $24 a year less).

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

Key differences

Price
Direct Meds $297/mo vs MEDVi $299/mo for compounded semaglutide (standing prices, no prepay or separate membership listed · about $24 a year less with Direct Meds)
Coverage
MEDVi 48 states (Direct Meds doesn't publish a state list)
Included
Direct Meds: medication, clinician visits, shipping; MEDVi: medication, clinician visits, shipping, coaching

How we compare providers

Direct Meds logo

Direct Meds

Affiliate partner

About $24 a year less for compounded semaglutide

semaglutide

$297/mo

Our score 6.4/10

MEDVi logo

MEDVi

Affiliate partner

Best for switching between compounded and brand-name GLP-1 through one provider

semaglutide

$299/mo

$179 first month

Our score 7.1/10

We may earn a commission if you sign up through these links. Partner status can affect which provider we feature; it never changes a score or a price.

Costs & coverage

Published prices with their terms attached. Yearly figures are modeled from the standing price and billing cadence. A check mark marks the better side, on like-for-like rows only.

Direct Meds

MEDVi

Price

Semaglutide / month

Better on this row: $297/mo

$299/mo

$179 first month

Semaglutide / year (modeled)

Better on this row: $3,564

$3,588

Oral semaglutide / month

$249/mo

$249/mo

Oral semaglutide / year (modeled)

$2,988

$2,988

Tirzepatide / month

$399/mo

Not listed

Oral tirzepatide / month

$299/mo

Not listed

Coverage

State availability

List not published

48 states

Oral option listed

Yes

Yes

Included in the price

Medication, clinician visits, shipping

Medication, clinician visits, shipping, coaching

Terms & safety

Price shown

Before intake

Before intake

Lab work

Not disclosed

Not required

Video visit

Not disclosed

Not required

Cancel anytime

No

Not disclosed

Minimum commitment

3-month prepay

Membership

Early-cancellation fee

Yes

Not disclosed

FDA warning letters

1 warning letter

1 warning letter

Provider facts checked

August 2026

August 2026

Every dose and plan: Direct Meds · MEDVi

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 540+ providers' prices on their own sites and email you when tracked prices move.

Which fits your priorities?

Only the points where these two differ, from the table above and each provider’s record.

Direct Meds logo

Choose Direct Meds if…

  • About $24 a year less than MEDVi for compounded semaglutide at standing prices
  • Lists compounded tirzepatide and oral compounded tirzepatide, which MEDVi doesn't price
  • Semaglutide and tirzepatide available in both injection and sublingual formats

What to weigh up

  • 1 FDA warning letter on record
  • No published state list; confirm yours at signup
  • FDA warning letter (Sept 2025) for marketing compounded GLP-1s as equivalent to FDA-approved drugs
MEDVi logo

Choose MEDVi if…

  • Publishes its full state list (48 states)
  • Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
  • Oral tablet and injectable formats

What to weigh up

  • 1 FDA warning letter on record
  • About $24 a year more than Direct Meds for compounded semaglutide

Explore the scoring factors

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Direct Meds

6.4/10

Overall

MEDVi

7.1/10

Value25%

6.0A
vs
B
6.0

Effectiveness25%

7.5A
vs
B
8.0

User Experience15%

6.5A
vs
B
7.5

Trust & Safety15%

3.8A
vs
B
6.8

Accessibility10%

8.0A
vs
B
8.0

Support10%

6.9A
vs
B
7.0

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

AgelessRx

Longevity-focused GLP-1 care with microdosing and brand-name options

Read full review →

From $139/mo

Get started →
7.2

Willow

Needle-free compounded semaglutide or tirzepatide tablets

Read full review →

From $299/mo

Get started →
7.6

SkinnyRx

Compounded semaglutide or tirzepatide with the consult and free overnight shipping in one price

Read full review →

From $149.25/mo

Get started →

Direct Meds vs MEDVi: FAQ

For compounded semaglutide, Direct Meds costs less: about $24 less a year at the standing price, with no prepay or separate membership listed (not a first-month promo). See Costs & coverage above for each medication side by side.
MEDVi scores higher overall at 7.1/10 versus 6.4/10. That said, Direct Meds remains a solid alternative.
Both Direct Meds and MEDVi are affiliate partners, meaning we may earn a commission if you sign up through our links. Our scores are assigned editorially using the same six-dimension framework for every provider — partnership never changes a score. We disclose every commercial relationship.
Direct Meds: $297, about $3,564 a year. MEDVi: $299, about $3,588 a year; first month $179. Direct Meds costs about $24 less a year at these prices.
Direct Meds doesn't publish a state list. MEDVi publishes 48 states. Where a list isn't published, confirm your state during sign-up before paying.
Direct Meds: cancel anytime — no; minimum commitment — 3-month prepay; early-cancellation fee — yes. MEDVi: cancel anytime — not disclosed; minimum commitment — Membership; early-cancellation fee — not disclosed. Check the provider's own terms before you buy.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Direct Meds and MEDVi head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.